Alcon Inc

ALC

Company Profile

  • Business description

    Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.

  • Contact

    Chemin de Blandonnet 8
    Vernier
    Geneva1214
    CHE

    T: +41 589112000

    https://www.alcon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    25,942

Stocks News & Analysis

stocks

CBA earnings: Business lending powers on, but costs and credit bear watching

Our view after the bank reports first quarter earnings.
stocks

Apple earnings review: Revenue beats estimates as memory crunch threatens margins

Apple shares are trading at record highs after posting solid results.
stocks

Nvidia: Cutting our fair value estimate by 19% given the firm’s CEO transition and turmoil

We’re reducing our long-term revenue estimates.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,204.5069.70-0.75%
CAC 408,368.917.550.09%
DAX 4026,749.9521.93-0.08%
Dow JONES (US)52,347.5550.460.10%
FTSE 10010,902.5639.470.36%
HKSE23,637.60370.95-1.55%
NASDAQ25,136.27229.82-0.91%
Nikkei 22561,142.35322.990.53%
NZX 50 Index14,173.6885.55-0.60%
S&P 5007,561.6730.73-0.40%
S&P/ASX 2009,082.2064.60-0.71%
SSE Composite Index3,634.3521.48-0.59%

Market Movers